http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-113192-C2

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-10022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55544
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2720-12134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2720-12122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6037
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-10034
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-101
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-01
filingDate 2012-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UA-113192-C2
titleOfInvention IMMUNOGENIC COMPOSITION AGAINST PIG TYPE 2 (PCV2) CIRCULOSIS
abstract The invention relates to an immunogenic composition against porcine circovirus type 2 (PCV2), which contains an antigenic peptide that is an arginine-enriched ORF2 peptide from PCV2, or a recombinant chimeric protein comprising from the amino terminus to the carboxyl end of the recombinant peptide chimeric peptide of ORF2 with PCV2, and the KDEL signal peptide. The invention also relates to a method for producing a PCV2 fragment comprising the arrangement of a DNA sequence encoding an arginine-enriched peptide of ORF2 from PCV2, and the expression of said DNA sequence to obtain an antigen fragment of an immunogenic composition against PCV2.
priorityDate 2011-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457586699
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365

Total number of triples: 30.